Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Aug 31, 2018
Company News
Sierra Oncology acquires momelotinib from Gilead
Read More
BioCentury
|
Nov 18, 2016
Clinical News
Momelotinib: Ph III SIMPLIFY-2 data
Read More
BioCentury
|
Nov 18, 2016
Clinical News
Momelotinib: Ph III SIMPLIFY-1 data
Read More
BioCentury
|
Nov 16, 2016
Clinical News
Mixed Phase III results for Gilead's momelotinib in myelofibrosis
Read More
BioCentury
|
Feb 12, 2016
Clinical News
Incyte discontinues Jakafi trials in solid tumors
Read More
BioCentury
|
Dec 18, 2015
Company News
Galapagos finds new filgotinib partner in Gilead
Read More
BioCentury
|
Jan 22, 2015
Tools & Techniques
Parsing resistance pathways
Barcoded cDNA screen can identify resistance pathways against cancer therapies
Read More
BioCentury
|
Dec 4, 2014
Distillery Therapeutics
Indication: Cancer
Read More
BioCentury
|
Mar 20, 2014
Distillery Therapeutics
Indication: Cancer
Read More
BioCentury
|
Dec 17, 2012
Company News
Gilead, YM BioSciences deal
Read More
Items per page:
10
1 - 10 of 37
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help